B型钠尿肽、D二聚体和同型半胱氨酸在急性肺栓塞临床诊断和危险分级中的应用价值

doi:10.3760/cma.j.issn.1007-1245.2021.06.022

国际医药卫生导报 ›› 2021, Vol. 27 ›› Issue (6): 875-877.DOI: 10.3760/cma.j.issn.1007-1245.2021.06.022

B型钠尿肽、D二聚体和同型半胱氨酸在急性肺栓塞临床诊断和危险分级中的应用价值

刘小毅¹, 杨薇², 陈涌泉³

¹中国人民解放军陆军第73集团军医院重症医学科,厦门 361003;
²中国人民解放军陆军第73集团军医院检验科,厦门 361003;
³福建医科大学附属厦门弘爱医院医学检验中心 361003

收稿日期:2020-09-21 出版日期:2021-03-15 发布日期:2021-04-15
通讯作者: 陈涌泉,Email:773993382@qq.com

Application value of B-type natriuretic peptide, D-dimer, and homocysteine in clinical diagnosis and risk classification of acute pulmonary embolism

Liu Xiaoyi¹, Yang Wei², Chen Yongquan³

¹Department of Intensive Care Unit, The 73rd Group Military Hospital of the Chinese People's Liberation Army Ground Force, Xiamen 361003, China;
²Department of Clinical Laboratory, The 73rd Group Military Hospital of the Chinese People's Liberation Army Ground Force, Xiamen 361003, China;
³Center of Medical Laboratory, Xiamen Humanity Hospital Affiliated to Fujian Medical University, Xiamen 361003, China

Received:2020-09-21 Online:2021-03-15 Published:2021-04-15
Contact: Chen Yongquan, Email: 773993382@qq.com

摘要/Abstract

摘要： 目的探讨B型钠尿肽(BNP)、D二聚体(DD)和同型半胱氨酸(Hcy)在急性肺栓塞(APE)临床诊断和危险分级中的应用价值。方法选取2018年7月至2020年6月本院重症监护室(ICU)收治的89例APE患者和同时期体检健康者30例作为研究对象,APE患者根据患者急性肺栓塞病情严重程度分为高危险组(36例)、中危险组(31例)、低危险组(22例),检测并分析各组BNP、DD和Hcy的检测结果。结果经单因素方差分析,不同危险等级APE患者组与健康对照组BNP、DD和Hcy水平不完全相同(均P<0.001),高危险组、中危险组和低危险组BNP和Hcy水平均高于健康对照组(均P<0.05),高危险组和中危险组DD水平高于低危险组和健康对照组(均P<0.05)。经ROC曲线分析,BNP、DD和Hcy的曲线下面积(AUC)分别为0.762、0.583和0.644,当BNP、DD和Hcy分别取153.62 μg/L、1.13 μg/L和15.24 μmol/L时具有最大诊断效能,BNP的敏感度和特异性分别为88.7%和82.4%,DD的敏感度和特异性分别为75.2%和79.3%,Hcy的敏感度和特异性分别为63.6%和90.8%。经Spearman相关性分析,BNP、DD和Hcy水平与APE患者危险分级呈正相关(r=0.736、0.715、0.628),差异均有统计学意义(均P<0.05)。结论 BNP、DD和Hcy水平检测在APE临床诊断和危险分级方面具有指导意义,临床上建议对于APE疑似患者同时进行该3项检测,以获取最佳的诊断准确性。

关键词: 急性肺栓塞, B型钠尿肽, D二聚体, 同型半胱氨酸

Abstract: Objective To explore the application value of B-type natriuretic peptide (BNP), D-dimer (DD), and homocysteine (Hcy) in the clinical diagnosis and risk classification of acute pulmonary embolism (APE). Methods A total of 89 APE patients admitted to the intensive care unit (ICU) of our hospital and 30 healthy physical examination people from July 2018 to June 2020 were selected as the research objects. According to the severity of APE, the patients were divided into high-risk group (36 cases), medium-risk group (31 cases), low-risk group (22 cases). The levels of BNP, DD, and Hcy in the three groups were detected and analyzed. Results Through one-way analysis of variance, the levels of BNP, DD, and Hcy in different risk grade APE patient groups and healthy control group were not exactly the same (all P<0.001), the BNP and Hcy levels of the high-risk group, medium-risk group, and low-risk group were higher than those of the healthy control group (all P<0.05), and the DD levels of the high-risk group and the medium-risk group were higher than those of the low-risk group and the healthy control group (all P<0.05). ROC curve analysis showed that the areas under the curves (AUC) of BNP, DD, and Hcy were 0.762, 0.583, and 0.644, respectively. When BNP, DD, and Hcy took 153.62 μg/L, 1.13 μg/L, and 15.24 μmol/L, they achieved the maximum diagnostic efficiency, with the sensitivity and specificity of 88.7% and 82.4% for BNP, 72.5% and 79.3% for DD, and 63.6% and 90.8% for Hcy. Spearman correlation analysis showed that the levels of BNP, DD, and Hcy were positively correlated with the risk classification of APE patients (r=0.736, 0.715, 0.628), with statistically significant differences (all P<0.05). Conclusion The levels of BNP, DD, and Hcy have important guiding significance in the clinical diagnosis and risk classification of APE. It is clinically recommended to perform these three tests at the same time for patients with suspected APE to obtain the best diagnostic accuracy.

Key words: Acute pulmonary embolism, B-type natriuretic peptide, D-dimer, Homocysteine

刘小毅, 杨薇, 陈涌泉. B型钠尿肽、D二聚体和同型半胱氨酸在急性肺栓塞临床诊断和危险分级中的应用价值[J]. 国际医药卫生导报, 2021, 27(6): 875-877.

Liu Xiaoyi, Yang Wei, Chen Yongquan. Application value of B-type natriuretic peptide, D-dimer, and homocysteine in clinical diagnosis and risk classification of acute pulmonary embolism[J]. International Medicine and Health Guidance News, 2021, 27(6): 875-877.

参考文献

[1] Martinez Licha CR, McCurdy CM, Maldonado SM, et al. Current Management of Acute Pulmonary Embolism[J]. Ann Thorac Cardiovasc Surg, 2020, 26(2):65-71. DOI: 10.5761/atcs.ra.19-00158.
[2] 张鑫,董丽霞,曹洁,等.急性肺栓塞患者复发的危险因素分析[J].中国呼吸与危重监护杂志,2018,17(5):514-517. DOI: 10.7507/1671-6205.201801054.
[3] 张捷,张杜超,杨磊,等.肺栓塞患者发病的危险因素[J].中国老年学杂志,2020,40(6):1203-1206. DOI: 10.3969/j.issn.1005-9202.2020.06.028.
[4] 万铠瑞,赖宁,马杰羚,等.2018年肺血栓栓塞症诊治与预防指南的质量评价[J].中华结核和呼吸杂志,2019,42(3):213-218. DOI: 10.3760/cma.j.issn.1001-0939. 2019. 03.012.
[5] Becattini C, Agnelli G, Lankeit M, et al.Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model[J]. Eur Respir J, 2016, 48(3):780-786. DOI: 10.1183/13993003. 00024-2016.
[6] 彭卫军,张海青,杨雯,等.CT肺动脉栓塞指数与急性肺栓塞病情严重程度相关性[J].现代仪器与医疗,2018,24(5):11-13. DOI: 10.11876/mimt201805005.
[7] Lewis RA, Durrington C, Condliffe R, et al.BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?[J]. Eur Respir Rev, 2020, 29(156):200009. DOI: 10.1183/16000617.0009-2020.
[8] 马腾,严激.血浆N末端B 型利钠肽原和心肌肌钙蛋白I对急性肺栓塞合并右心功能障碍患者病情评估的临床价值[J].中国循环杂志,2015,30(5):446-448. DOI: 10.3969/j.issn.1000-3614.2015.05.009.
[9] Sendama W, Musgrave KM.Decision-Making with D-Dimer in the Diagnosis of Pulmonary Embolism[J]. Am J Med, 2018, 131(12):1438-1443. DOI: 10.1016/j.amjmed.2018.08.006.
[10] Zaric BL, Obradovic M, Bajic V, et al.Homocysteine and Hyperhomocysteinaemia[J]. Curr Med Chem, 2019, 26(16):2948-2961. DOI: 10.2174/0929867325666180313105949.
[11] 李博雅,卢巍.高同型半胱氨酸血症与静脉血栓栓塞症相关性研究[J].临床军医杂志,2019,47(8):883-886. DOI: 10.16680/j.1671-3826.2019.08.47.
[12] 李双拾,远丽娜.BNP、TNI、Hcy和UA与急性肺栓塞相关性分析[J].解放军预防医学杂志,2019,37(11):67-68. DOI:10.13704/j.cnki.jyyx.2019.11.075.
[13] 朱亦林,袁园,陈继中.血清高敏肌钙蛋白、B型脑尿钠肽及D-二聚体在急性肺栓塞诊断和危险分层中的应用价值[J/CD].中西医结合心血管病电子杂志,2018,6(27):76. DOI: 10.3969/j.issn.2095-6681.2018.27.058.

B型钠尿肽、D二聚体和同型半胱氨酸在急性肺栓塞临床诊断和危险分级中的应用价值

Application value of B-type natriuretic peptide, D-dimer, and homocysteine in clinical diagnosis and risk classification of acute pulmonary embolism

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics